Prestige Consumer Healthcare Inc. Common Stock (PBH)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 19% below Graham Number — thin margin of safety
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 10.5% — below-average profitability
Prestige Consumer Healthcare Inc. Common Stock (PBH) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NYSE , with a market capitalisation of $2.3 billion . Key value metrics: P/E ratio 11.9, P/B ratio 1.24, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Prestige Consumer Healthcare Inc. Common Stock — Fundamental Analysis Summary
Prestige Consumer Healthcare Inc. Common Stock (PBH) is trading 19% below its Graham Number of $61.12, offering a thin margin of safety. The stock carries a low trailing P/E ratio of 11.9x.
On financial health, PBH shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 10.5% (sector average: -20.6%), and manageable leverage with a debt-to-equity ratio of 0.53.
StockPik's composite Value Score for PBH is 84/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PBH reports a solid gross margin of 55.6% (sector average: 39.4%) and a strong operating margin of 29.7%.
PBH shows revenue declining at 4% year-over-year, with earnings declining at 11%.